Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.1Revenue $M1.3Net Margin (%)-3,552.9Altman Z-Score-22.0
Enterprise Value $M67.7EPS $-0.9Operating Margin %-3,330.3Piotroski F-Score--
P/E(ttm)--Beneish M-Score18.1Pre-tax Margin (%)-3,552.9Higher ROA y-yN
Price/Book7.110-y EBITDA Growth Rate %--Quick Ratio2.3Cash flow > EarningsN
Price/Sales60.45-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-64.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-174.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M55.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AVEOSeth Klarman 2014-12-31 Sold Out -0.07%$0.65 - $1.17
($0.91)
$ 1.4256%Sold Out0
AVEOGeorge Soros 2014-09-30 Sold Out $1.09 - $1.79
($1.26)
$ 1.4213%Sold Out0
AVEOGeorge Soros 2014-06-30 Buy $1.02 - $1.72
($1.29)
$ 1.4210%New holding49,076
AVEOSeth Klarman 2013-06-30 Reduce-0.26%$2.34 - $8.27
($4.27)
$ 1.42-67%Reduce 21.90%3,829,350
AVEOGeorge Soros 2011-12-31 Sold Out -0.0031%$14.53 - $17.35
($8.42)
$ 1.42-83%Sold Out0
AVEOSeth Klarman 2011-09-30 Add0.29%$15.12 - $20.77
($17.66)
$ 1.42-92%Add 12.79%5,000,000
AVEOGeorge Soros 2011-09-30 Reduce-0.04%$15.12 - $20.77
($17.66)
$ 1.42-92%Reduce 92.80%11,600
AVEOSeth Klarman 2011-06-30 Add0.78%$13.06 - $20.66
($16.79)
$ 1.42-92%Add 25.76%4,433,010
AVEOGeorge Soros 2011-06-30 Buy 0.05%$13.06 - $20.66
($16.79)
$ 1.42-92%New holding161,000
AVEOSeth Klarman 2011-03-31 Add1.15%$13.15 - $15.02
($14.21)
$ 1.42-90%Add 76.25%3,525,000
AVEOSeth Klarman 2010-12-31 Buy 1.68%$13.84 - $17.41
($15.14)
$ 1.42-91%New holding2,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AVEO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dallas Matthew DVP, Finance 2015-01-16Sell3,075$0.8273.17 view
Gyuris JenoSVP, Chief Scientific Officer 2015-01-07Sell4,484$0.877.5 view
Vittiglio JosephSVP, General Counsel 2015-01-07Sell4,484$0.877.5 view
Dallas Matthew DVP, Finance 2015-01-07Sell519$0.877.5 view
BAILEY MICHAEL PPresident & CEO 2015-01-07Sell4,484$0.877.5 view
Dallas Matthew DVP, Finance 2014-07-01Sell0$077.5 view
BAILEY MICHAEL PChief Business Officer 2014-01-30Sell5,430$1.64-13.41 view
Slichenmyer WilliamChief Medical Officer 2014-01-30Sell5,430$1.64-13.41 view
Gyuris JenoSVP, Chief Scientific Officer 2014-01-30Sell5,430$1.64-13.41 view
Vittiglio JosephSVP, General Counsel 2014-01-30Sell5,430$1.64-13.41 view

Quarterly/Annual Reports about AVEO:

    News about AVEO:

    Articles On GuruFocus.com
    Wild Card Wonders, Shopping for 52-Week Lows Sep 28 2013 
    Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low Sep 03 2013 
    comment on AVEO Mar 15 2013 
    comment on AVEO Mar 15 2013 
    Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA Dec 16 2012 
    Seth Klarman’s Baupost Group Buys Microsoft Corp., BP, Allied Nevada Gold, Sells Audiovox Corp. Aug 12 2011 
    Seth Klarman’s Baupost Group Q1 Portfolio Update; Buys ANV, SCMR, PDLI, AVEO May 14 2011 
    AVEO Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 11 2011 
    Two Picks from Seth Klarman: PDLI, AVEO Feb 22 2011 
    Hedge Fund Baupost Group buys PDLI, AVEO, ALR, Sells LSTZA, UFS, SLRC, EXXI Feb 11 2011 

    More From Other Websites
    AVEO Pharmaceuticals, Inc. Earnings Analysis: By the Numbers Q2, 2015 Aug 26 2015
    AVEO PHARMACEUTICALS INC Financials Aug 22 2015
    What Lit a Fire Under These 3 Pharma Stocks Aug 22 2015
    Edited Transcript of AVEO earnings conference call or presentation 10-Aug-15 2:00pm GMT Aug 20 2015
    AVEO Pharmaceuticals (AVEO) in Focus: Stock Soars 45.3% Aug 18 2015
    ​Aveo, the Cambridge biotech that refuses to die, sees stock jump after $326M deal Aug 17 2015
    Repeat Performance In Aveo Pharmaceuticals After Spike In Price Aug 17 2015
    Is AVEO the Next Aquinox for Traders? Aug 17 2015
    Stocks to Watch: Tesla, Zulily, Pentair, Estee Lauder Aug 17 2015
    AVEO Announces Exclusive Worldwide License Agreement for the Development and Commercialization of... Aug 17 2015
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Aug 17 2015
    AVEO Announces Exclusive Worldwide License Agreement for the Development and Commercialization of... Aug 17 2015
    10-Q for AVEO Pharmaceuticals, Inc. Aug 13 2015
    ​Celldex and the limits of ‘overall survival benefit’ in cancer trials Aug 13 2015
    AVEO Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog Aug 11 2015
    Aveo Pharmaceuticals Inc Earnings Call scheduled for 10:00 am ET today Aug 10 2015
    AVEO (AVEO) Reports Narrower-than-Expected Loss in Q2 - Tale of the Tape Aug 10 2015
    AVEO Oncology Reports Second Quarter 2015 Financial Results Aug 10 2015
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 10 2015
    AVEO reports 2Q loss Aug 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK